Approved for ARALAST NP is an Alpha 1 -Proteinase Inhibitor (Alpha 1 -PI) indicated for chronic augmentation therapy in adults with clinically evident emphysema due to severe congenital deficiency of Alpha 1 -PI (alpha 1 -antitrypsin deficiency). ARALAST NP increases antigenic and functional (anti-neutrophil elastase capacity, ANEC) serum levels and antigenic lung epithelial lining fluid levels…
Loading full data from Know Your Drugs Institute…